Tag: Christopher Porter
Seaport Therapeutics secures $100M to harness Monash invention
Seaport Therapeutics, a biopharmaceutical company in the clinical stage, centred on an innovative drug delivery system initially created by researchers from Monash University, announced the completion of a Series A funding round, which raised USD 100 million (AUD 154 million).
Featured Article
What spending reveals about downstream consumer demand for manufactured goods
For manufacturers supplying consumer-facing markets, understanding demand conditions has become increasingly important in an environment shaped by cautious spending, rising costs and intense competition.
